Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |